DrugPatentWatch Database Preview
Drugs in Development Information for DSM265
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for DSM265?
DSM265 is an investigational drug.
There have been 7 clinical trials for DSM265.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Malaria, Malaria, Falciparum, and Malaria, Vivax. The leading clinical trial sponsors are Medicines for Malaria Venture, AbbVie, and Q-Pharm Pty Limited.
There are two US patents protecting this investigational drug and thirty-four international patents.
Summary for DSM265
| US Patents | 2 |
| International Patents | 34 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 12 |
Recent Clinical Trials for DSM265
| Title | Sponsor | Phase |
|---|---|---|
| Malaria: Relative Bioavailability and Food Effect of DSM265 | AbbVie | Phase 1 |
| Malaria: Relative Bioavailability and Food Effect of DSM265 | Medicines for Malaria Venture | Phase 1 |
| Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects | AbbVie | Phase 1 |
Clinical Trial Summary for DSM265
Top disease conditions for DSM265
Top clinical trial sponsors for DSM265
US Patents for DSM265
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| DSM265 | Start Trial | Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH) UNIVERSITY OF WASHINGTON (Seattle, WA) | Start Trial |
| DSM265 | Start Trial | Substituted 2-alkyl-1-OXO-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carb- oxamides for antimalarial therapies | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (Memphis, TN) MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for DSM265
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| DSM265 | Brazil | 112012007179 | 2029-09-29 | Start Trial |
| DSM265 | Canada | 2775354 | 2029-09-29 | Start Trial |
| DSM265 | China | 102741255 | 2029-09-29 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
